Neighbourly Pharmacy Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Neighbourly Pharmacy hat ein Gesamteigenkapital von CA$590.6M und eine Gesamtverschuldung von CA$263.1M, wodurch sich der Verschuldungsgrad auf 44.5% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen CA$1.1B bzw. CA$521.8M. Neighbourly Pharmacy Das EBIT des Unternehmens beträgt CA$13.1M, so dass der Zinsdeckungsgrad 0.4 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von CA$17.5M.

Wichtige Informationen

44.5%

Verhältnis von Schulden zu Eigenkapital

CA$263.07m

Verschuldung

Zinsdeckungsgrad	0.4x
Bargeld	CA$17.49m
Eigenkapital	CA$590.65m
Gesamtverbindlichkeiten	CA$521.83m
Gesamtvermögen	CA$1.11b

Jüngste Berichte zur Finanzlage

Recent updates

Neighbourly Pharmacy (TSE:NBLY) Will Pay A Dividend Of CA$0.045

Aug 15

Estimating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

Mar 22

Results: Neighbourly Pharmacy Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts

Feb 17

Calculating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

Dec 09

Neighbourly Pharmacy's (TSE:NBLY) Robust Earnings Are Supported By Other Strong Factors

Aug 10

News Flash: Analysts Just Made A Substantial Upgrade To Their Neighbourly Pharmacy Inc. (TSE:NBLY) Forecasts

Mar 21

Is There An Opportunity With Neighbourly Pharmacy Inc.'s (TSE:NBLY) 48% Undervaluation?

Feb 27

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: NBLYDie kurzfristigen Aktiva des Unternehmens (CA$160.1M) übersteigen seine kurzfristigen Passiva (CA$140.5M).

Langfristige Verbindlichkeiten: NBLYDie kurzfristigen Vermögenswerte des Unternehmens (CA$160.1M) decken seine langfristigen Verbindlichkeiten (CA$381.3M) nicht.

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: NBLYDie Nettoverschuldung im Verhältnis zum Eigenkapital (41.6%) wird als hoch angesehen.

Schulden abbauen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob das Verhältnis von Schulden zu Eigenkapital in den letzten 5 Jahren gesunken ist ( NBLY).

Bilanz

Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: Obwohl NBLY unrentabel ist, verfügt es über eine ausreichende Cash-Runway für mehr als 3 Jahre, wenn es seinen derzeitigen positiven freier Cashflow beibehält.

Vorhersage Cash Runway: NBLY ist unrentabel, verfügt aber über eine ausreichende Liquiditätsreserve für mehr als drei Jahre, da der freie Cashflow positiv ist und um 26.9% pro Jahr wächst.

Neighbourly Pharmacy Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Neighbourly Pharmacy Inc. COM to Be Deleted from OTC Equity

Neighbourly Closes Go-Private Deal with Persistence

Recent updates

Neighbourly Pharmacy Inc. Announces CFO Changes

Neighbourly Pharmacy Inc. COM to Be Deleted from OTC Equity

Neighbourly Closes Go-Private Deal with Persistence

Third quarter 2024 earnings released: CA$0.11 loss per share (vs CA$0.20 loss in 3Q 2023)

Price target decreased by 12% to CA$18.80

Neighbourly Pharmacy Inc. Announces Executive Changes

Neighbourly Pharmacy Inc. to Report Q3, 2024 Results on Feb 13, 2024

Upcoming dividend of CA$0.045 per share at 1.0% yield

Now 22% undervalued

Neighbourly Pharmacy Inc. to Report Q2, 2024 Results on Oct 24, 2023

PCP GP, L.P. entered into a letter of intent to acquire remaining all unknown minority stake in Neighbourly Pharmacy Inc. (TSX:NBLY) for CAD 470 million.

New major risk - Share price stability

Upcoming dividend of CA$0.045 per share at 1.1% yield

Neighbourly Pharmacy (TSE:NBLY) Will Pay A Dividend Of CA$0.045

Forecast breakeven date pushed back to 2025

First quarter 2024 earnings released: CA$0.27 loss per share (vs CA$0.029 loss in 1Q 2023)

Neighbourly Pharmacy Inc. to Report Q1, 2024 Results on Aug 01, 2023

Upcoming dividend of CA$0.045 per share at 1.1% yield

Independent Chairman of the Board recently bought CA$599k worth of stock

Neighbourly Pharmacy Inc. Announces Quarterly Dividend, Payable on August 3, 2023

Full year 2023 earnings released: CA$0.37 loss per share (vs CA$2.57 loss in FY 2022)

Neighbourly Pharmacy Inc. (TSX:NBLY) entered into a binding agreement to acquire Seven Pharmacies in Western Canada.

Neighbourly Pharmacy Inc. (TSX:NBLY) has entered into a binding agreement to acquire Three pharmacies in Ontario.

Neighbourly Pharmacy Inc., Annual General Meeting, Aug 01, 2023

Neighbourly Pharmacy Inc. to Report Q4, 2023 Results on Jun 08, 2023

Estimating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

Upcoming dividend of CA$0.045 per share at 0.7% yield

CEO & Director recently bought CA$272k worth of stock

Forecast breakeven date pushed back to 2024

Results: Neighbourly Pharmacy Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts

Neighbourly Pharmacy Inc. Announces Quarterly Dividend, Payable on April 11, 2023

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 42%

Neighbourly Pharmacy Inc. to Report Q3, 2023 Results on Feb 14, 2023

Neighbourly Pharmacy Inc. Announces CEO Changes

Neighbourly Pharmacy Inc. (TSX:NBLY) completed the acquisition of Cloverdale Pharmacy Ltd. and Steveston Health Centre Ltd. from CloudMD Software & Services Inc. (TSXV:DOC)

Calculating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

High number of new and inexperienced directors

Neighbourly Pharmacy Inc. Announces Quarterly Dividend, Payable on December 20, 2022

Consensus forecasts updated

Neighbourly Pharmacy Inc. (TSX:NBLY) acquired Assets of a Retail Pharmacy Located in Manitoba.

Neighbourly Pharmacy Inc. (TSX:NBLY) enter into a binding agreement to acquire Two Community Pharmacies Located in British Columbia.

Consensus forecasts updated

Now 21% undervalued after recent price drop

Neighbourly Pharmacy Inc. Appoints Billy Wong as CFO to Succeed Terri Smyth

Upcoming dividend of CA$0.045 per share

Neighbourly Pharmacy's (TSE:NBLY) Robust Earnings Are Supported By Other Strong Factors

First quarter 2023 earnings: EPS misses analyst expectations

Neighbourly Pharmacy Inc. Declares Dividend on Common Share for the First Quarter Ended June 18, 2022, Payable on September 27, 2022

Upcoming dividend of CA$0.045 per share

Neighbourly Pharmacy Inc. (TSX:NBLY) completed the acquisition of Rubicon Pharmacies Canada Inc.

Full year 2022 earnings: EPS misses analyst expectations

Price target decreased to CA$33.44

Neighbourly Pharmacy Inc. Announces Quarterly Dividend, Payable on August 18, 2022

Neighbourly Pharmacy Inc. to Report Q1, 2023 Results on Aug 02, 2022

Neighbourly Pharmacy Inc., Annual General Meeting, Aug 02, 2022

Neighbourly Pharmacy Inc. to Report Q4, 2022 Results on Jun 23, 2022

High number of new and inexperienced directors

Neighbourly Pharmacy Inc. announced that it has received CAD 138.163875 million in funding from PCP GP, L.P.

News Flash: Analysts Just Made A Substantial Upgrade To Their Neighbourly Pharmacy Inc. (TSE:NBLY) Forecasts

Upcoming dividend of CA$0.045 per share

Is There An Opportunity With Neighbourly Pharmacy Inc.'s (TSE:NBLY) 48% Undervaluation?

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Neighbourly Pharmacy Inc. (TSX:NBLY) entered into an agreement to acquire one additional pharmacy in Canada.

Consensus forecasts updated

Upcoming dividend of CA$0.045 per share

Second quarter 2022 earnings released: CA$0.11 loss per share (vs CA$24.48 loss in 2Q 2021)

Upcoming dividend of CA$0.045 per share

Forecast breakeven pushed back to 2023

Full year 2021 earnings released: CA$19.88 loss per share (vs CA$5.08 loss in FY 2020)

Neighbourly Pharmacy Inc. (TSX:NBLY) acquired One Pharmacy in Canada.

Neighbourly Pharmacy Inc. has completed an IPO in the amount of CAD 175.015 million.

Analyse der Finanzlage